WallStreetZenWallStreetZen

NASDAQ: HCM
Hutchmed Ltd Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Hutchmed earnings were $17.9M for the trailing 12 months ending Jun 30, 2026, with -96.3% growth year over year. The latest HCM earnings report on Jun 30, 2026 announced Q2 2026 earnings of N/A, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, HCM reported annual earnings of $456.9M, with 1,111% growth.

HCM past earnings growth

How has HCM's earnings growth performed historically?

Company
-96.3%
Industry
103.37%
Market
91.1%
HCM's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
HCM's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance

HCM earnings history

Current Revenue
$549.1M
Current Earnings
$17.9M
Current Profit Margin
3.3%

HCM Return on Equity

Current Company
1.4%
Current Industry
1.7%
Current Market
28.8%
HCM's Return on Equity (1.4%)... subscribe to Premium to read more.
High Return on Equity Performance

HCM Return on Assets

Current Company
1%
Current Industry
4%
HCM is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when HCM announces earnings.

HCM Return on Capital Employed

Current Company
1.53%
Current Industry
9.5%
HCM has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

HCM vs Pharmaceutical Stocks

TickerEBITDAEarningsY/Y EarningsEPS
HCMN/A$17.88M-96.30%$0.10
TRLV-$101.75M-$473.30MN/A-$2.45
PBH$320.69M$172.01M+0.11%$3.58
BHC$2.04B-$1.10BN/A-$2.96
PRGO-$1.13B-$1.73BN/A-$12.52
View Top Pharmaceutical Stocks

Hutchmed Earnings Reports & History FAQ

What were Hutchmed's earnings last quarter?

On HCM's earnings call on Jul 30, 2026, Hutchmed (NASDAQ: HCM) reported Q2 2026 earnings per share (EPS) of N/A, up N/A year over year. Total HCM earnings for the quarter were N/A. In the same quarter last year, Hutchmed's earnings per share (EPS) was N/A.

If you're new to stock investing, here's how to buy Hutchmed stock.

Is Hutchmed profitable or losing money?

As of the last Hutchmed earnings report, Hutchmed is currently profitable. Hutchmed's net profit (also called net income) for the twelve months ending Jun 30, 2026 was $17.88 million, a 96.17% decrease year over year.

What was HCM's earnings growth in the past year?

As of Hutchmed's earnings date in Jul 30, 2026, Hutchmed's earnings has grown -96.3% year over year. This is 199.66 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry earnings growth rate of 103.37%. HCM earnings in the past year totalled $17.88 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.